Although a recent study indicated that CD93 is important for maintaining endothelial barrier function and limiting metastatic dissemination (Vemuri et al. , 2024), a series of experimental research focusing on non-metastatic tumor found either knockout or blockade using a monoclonal antibody significantly reducing neovascular formation and tumor growth. The gene discussed is CD93; the disease is neoplasm.